DRUGS

ADMINISTRATIVE ORDERS | BUREAU CIRCULARS | MEMORANDUM CIRCULARS

DRUGS

(You need to download the Adobe Reader to access the files / Issuances)

BFAD ISSUANCE	Date Issued	Date Posted	SUBJECT
AO 2006-0021	10 Aug 2006		Supplemental Guidelines to Administrative Order (AO) 67 s. 1987, Revised Rules and Regulations on Registration of Pharmaceutical Products and Bureau Circular 05 s. 1997 in evaluating New Drug Applications
AO 2005-31	07 Dec 2005		Guidelines and Procedure for the Issuance of the Principal Certificate of Product Registration and the Listing of Identical Drug Products based on the Identity of Manufacturer and Pharmaceutical Formulation
AO 2005-30	07 Dec 2005		Guidelines and Procedure for the Automatic Renewal of the Certificate of Product Registration issued by the Bureau of Food and Drugs
AO 16 s 2005	21 June 2005		General Policies and Guidelines Governing Brand Names of Products for Registration with the Bureau of Food and Drugs
AO 11 s. 2005	4 Apr 2005		Supplemental Guidelines to Administrative Order No. 144 series 2004, entitled: "Guidelines for the Establishment and Operations of Botika ng Barangays (BnB) and Pharmaceutical Distribution Networks (PDNs)" relative to the inclusion of other drugs which are classified as Prescription Drugs and Other Related Matters
AO 8 s 2005	18 April 2005		Policy and Requirements for Availing of Special Permit for Restricted Use of Unregistered Drug and Test Kits for Human Immune Deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS)
AO 7 s 2005	31 March 2005		Amending AO No. 142 s 2004 by providing exemption from the requirement of Certificate of Product Registration for all goods procured through UNICEF, UNDP, WHO and GDF
AO 1 s 2005	3 Jan 2005		Revised Polices and Guidelines Governing Patent and Trade Secret Rights in relation to the Registration of Pharmaceutical Products
AO 184 s 2004	28 Dec 2004		Guidelines on the Registration of Traditionally-Used Herbal Products
AO 177 s. 2004	12 Nov 2004		Amendment to AO No. 171 s. 2004 on the Policies and Guidelines to Implement the Relevant Provisions of Republic Act 9257, otherwise known as the "Expanded Senior Citizen Act of 2003"
AO 172 s. 2004	16 Sep 2004		Guidelines on the Registration of Herbal Medicines
AO 171 s 2004	1 Oct 2004		Policies and Guidelines to Implement the Relevant Provisions of Republic Act 9257, otherwise known as the "Expanded Senior Citizens Act of 2003"
AO 170 s 2004	30 Sep 2004		Policies and Guidelines Governing Intellectual Property Rights in relation to Registration of Pharmaceutical Products
AO 169 s 2004	6 Sep 2004		Implementing Guidelines for the Exclusive Use of Generic Names and Generic Terminology in all Prescriptions and Orders in all DOH Facilities
AO 144 s. 2004	7 May 2004		Guidelines (Establishment & Operation of Botika ng Barangays (BnB) & Pharmaceutical Distribution Networks (PDNs)
AO 142 s. 2004	31 Mar 2004		Bureau of Food and Drugs (BFAD)'s issuance of Certificate of Product Registration for Foreign Assisted Projects Procurement and Laboratory Testing of Pharmaceutical and biological Products Procured by and/or delivered to the Department of Health (DOH)
AO 134 s. 2004	9 Jan 2004		Guidelines Governing the Registration and Performance Evaluation of Drug Screening Test Kits and Reagents
AO 90 s. 2003	18 Sep 2003		Reclassification and revision in the use of Hydroquinone and / or Tretinoin (RETINOIC ACID) preparations
AO 64 s. 2003	1 Jul 2003		Policy Guidelines on the Operationalization of Botika ng Barangays (BnBs) by the Center for health Development (CHD)
AO 54-A s. 2003	6 Jun 2003		Guidelines on the Processing and Clearance of Importations through Donations by the Department of Health
AO 34 s 2003	2 Apr 2003		Guidelines in the operationalization of Botika ng Barangay at CHD III Pilot Areas
AO 163 s. 2002	16 Oct 2002		Implementing Guidelines and Procedures in the Procurement and Requisition of Drugs and Medicines by the Department of Health Pursuant to Executive Order No. 49 dated January 21, 1993
AO 103 s. 2002	23 Apr 2002		Batch Certification of Antibiotics
AO 70 s. 2002	03 Jan 2002		Licensing of Botika ng Barangay (BnB) in Various Local Government Units
AO 53 s. 2001	09 Oct 2001		Recalling Administrative Order No. 40 s. 2001
AO 50 s 2001	17 Sep 2001		Revised 2001 Schedule of Fees and Charges for the Corresponding Services rendered by the Bureau of Food and Drugs
AO 47-A s. 2001	30 Aug 2001		Rules and Regulations on the Registration, Including Approval and Conduct of Clinical Trials, and Lot or Batch Release Certification of Vaccines and Biologic Product
AO 40 s. 2001	27 Aug 2001		Allowing Drug Manufacturers and Supplies Without CPR’s to Participate in the Bidding of the DOH Central Office.
AO 34 s. 2001	10 Jul 2001		Provisional Accreditation of DOH Drugs and Medical Supplies
AO 27 s. 2001	19 Jun 2001		Rules and Regulations for Licensing Local Manufacturers of Vaccines and Biologic Products
AO 3 s 2001	6 Mar 2001		Recalling AO No, 99 s 2000 Providing for the banning and Withdrawal of the Fixed Dose Combination drug product Loratidine+Pseudoephedrine (Clarinase) from the marker
AO 1 s. 2001	26 Feb 2001		Granting of Provisional Accreditation Pharmaceutical Suppliers
AO 177 s. 2001	24 Jan 2001		Amendment to Administrative Order No. 117s. 2000 Relative to the Guidelines on the Accreditation of Suppliers of Medical Equipment, Parts, Accessories and Medical Equipment Repair Shop
AO 163b s 2000	11 Dec 2000		Revised Schedule of Fees and Charges for the services rendered by the Bureau of Food and Drugs
AO 163 s. 2000	04 Dec 2000		Reclassifying All Pharmaceutical Products Containing More Than 25mg To 50mg Of Phenylpropanolamine To Prescription Drugs And Prohibiting the Registration of those Containing More than 50mg
AO 119 s. 2000	25 Sept 2000		Additional Guidelines on the Promotion of Over-The-Counter Drugs OTC to the Public
AO 107 s 2000	04 Sep 2000		Amendment/Addendum to AO 51 Sec. 9.1, 9.3, 9.4 and 10.2 s 1988. Reconstitution and Strengthening of the Membership of the Therapeutics Committee at the Centers for Health Development, Special Hospitals, National Medical Centers, Regional Medical Centers, Regional Hospitals and Sanitaria
AO 85 s. 2000	14 Jul 2000		Registration Requirement for a Government Agency Importing a Pharmaceutical Product with a Registered Counterpart Brand in the Philippines
AO 82 s. 2000	13 Jul 2000		Policies and Guidelines Governing Sale by Drug Outlets of Generic Alternative at Discounted Price
AO 49a s 2000	9 May 2000		Policy Guidelines in the Implementation/Operations of the DOH Botica in all DOH Retained Hospitals
AO 23-C s. 2000	09 Mar 2000		Policies and Guidelines on Over-the-Counter (OTC) Drug Products
AO 23 s 2000	2 Mar 2000		Implementing Rules and Regulations of RA NO. 8423 otherwise known as The Traditional and Alternative Medicine Act of 1997
AO 54 s. 1999	22 Dec 1999		Change of Manufacturers of Drug Products in Compliance with the CGMP Requirements
AO 48-C s. 1999	21 Nov 1999		Submission of Suggested Retail Price of Pharmaceutical Product as Additional Requirement for Product Registration
AO 43-A s. 1999	11 Oct 1999		Amendment of Administrative Order No. 220 s. 1974 Current Good Manufacturing Practice.
AO 43 s. 1999	29 Sep 1999		Current Good Manufacturing Practice Guidelines For Drugs
AO 41-A s. 1999	29 Sep 1999		Fee For Re-Submission of Application for Initial or Renewal Registration of Pharmaceutical Products Previously Disapproved Pursuant to Bureau of Food and Drugs (BFAD) Bureau Circular No. 6 S. 1999
AO 10 s. 1997	29 May 1997		Waiver of Test Analysis on Antibiotics Preparations and List B Prime Drugs
AO 31 s 1996	26 Aug 1996		Guidelines in the Strengthening of the Implementation of the "Project Murang Gamot Presyong DOH"
AO 28 s 1996	31 Jul 1996		Standard Minimum Advertising Message for Anti-Diarrheal Preparations of Drug Products
AO 23-A s. 1996	05 Jul 1996		Guidelines on the Development and Establishment of Botica ng Barangay
AO 38 s. 1994	18 Oct 1994		Recording of Non-Prescription Cough Preparations Subject to Abuse
AO 4 s. 1992	03 Nov 1992		Policy and Requirements for Availing of Compassionate Special Permit (CSP) for Restricted Use of Unregistered Drug and Device Product/Preparation
AO 42 s. 1992	19 Aug 1992		Regulation Part C-10: Drug Registration Of Herbal and/or Traditional Drugs Both Local And Imported
AO 117 s. 1992	17 Jan 1992		Providing for the Classification of Household Remedies
AO 115 s. 1991	08 Nov 1991		Providing for the Classification of Household Remedies
AO 111b s 1991	15 Oct 1991		Rules and Regulations on Registrations to Implement Prescribing Requirements for the Veterinary Drugs and Products
AO 111a s 1991	7 Oct 1991		Rules and Regulations on Registration of Veterinary Drugs and Products
AO 110 s. 1991	19 Jun 1991		Re-scheduling of Mandatory Use of Generic Labels for Pharmaceutical Products Containing Four of More Active Ingredients under the Coverage of Administrative Order No. 99 s. 1990
AO 106 s. 1991	16 May 1991		Guidelines on Prescribing of Multiactive-Ingredient Fixed-Dose Combination Drug Products
AO 107 s. 1991	16 May 1991		Guidelines on Dispensing of Multiactive-Ingredient Fixed-Dose Combination Drug Products
AO 105 s. 1991	15 Apr 1991		Requirement for Labeling Materials of Veterinary Drug products
AO 99 s 1990	3 Dec 1990		Requirements for Labelling Materials of Categories of Pharmaceutical Products containing four or more active ingredients outside the coverage of AO 85 s 1990.
AO 96 s 1990	19 Dec 1990		Guidelines on the Registration of Fixed-Dose Combination Drug Products
AO 90 s 1990	23 April 1990		Amendment to AO 62 s 1989 re: Rules and Regulations to Impalement Prescribing Requirements
AO 85 s 1990	15 Feb 1990		Requirements for Labelling Materials of Certain Categories of Products containing two or more active ingredients
AO 79 s. 1989	18 Sep 1989		Transitional Remedial Labeling in Compliance with R.A. 6675
AO 67 s. 1989	15 Sep 1989		Revised Rules and Regulations on Registration of Pharmaceutical Products
AO 66 s 1989	15 Mar 1989		Rules and Regulation on the Process of Review and Evaluation of Questioned Drug or Drug Products
AO 65 s. 1989	13 Mar 1989		Guidelines on Advertisement and Promotions to Implement The Generics Act of 1988
AO 63 s 1989	13 Mar 1989		Rules and Regulations to Implement Dispensing Requirements under the Generic Act of 1988 (RA No 6675)
AO 62 s 1989	9 Mar 1989		Rules and Regulations to Implement Prescribing Requirements under the Generic Act of 1988 (RA No 6675)
AO 56 s. 1989	03 Jan 1989		Revised Regulations for the Licensing of Drug Establishments and Outlets
AO 55 s. 1988	17 Dec 1988		Requirements for Labelling Materials of Pharmaceutical Products
AO 51 s 1988	16 Nov 1988		Implementing Guidelines for Department of Health Compliance with Republic Act 6675 (Generic Act of 1988)
AO 32 s 1987	23 Nov 1987		Further Amending AO No. 101 s 1969 Relative to Registration of Drugs and Pharmaceutical Specialties
AO 7 s 1986	30 Jan 1986		Amending AO No. 133 s 196 s 1985 Re: Guidelines on the evaluation and registration of Fixed Dose Combination
AO 133 s 1985	9 Oct 1985		Guidelines on the evaluation and registration of Fixed Dose Combination Drugs
AO 106a s 1985	25 Jan 1985		amendments to AO No. 60 s 1968 on Regulations Governing the Operation of Drug Establishments
AO 99a s 1984	14 Aug 1984		Regulation Part C-11: Listing of Local Herbal and/or Traditional Drugs
AO 76 s 1984	24 Jan 1984		Guidelines to be observed by FDA (BFAD) in clearance of name relative to food, drugs and cosmetics
AO 72 s 1983	6 Sep 1983		Seizure and Confiscation of Violative Food, Drug and Cosmetics, for the protection of the interest of consumers
AO 42 s 1982	19 Aug 1992		Regulation Part C-10: Drug Registration of Herbal and/or Traditional Drugs Both Local and Importer
AO 42 s 1979	19 Jul 1979		Clarification on AO 38 s 1979 restricting the use of Several brand names for a formulation
AO 39 s. 1979	15 Jun 1979		Delisting of Fertilizer, Pesticide, Insecticide and other Economic Poison as Household Hazardous Substances
AO 38 s. 1979	15 June 1979		Restriction on the Use of Several Brand Names for a Formulation of a Drug or Pharmaceutical Specialty
AO 34 s 1979	11 Jun 1979		The Need and Role of a Medical Director in the Pharmaceutical Industry
AO 312 s. 1977	17 Jan 1977		Household Hazardous Substances
AO 311 s. 1977	17 Jan 1977		Labeling Requirements of Hazardous Substances
AO 303 s. 1976	03 Sep 1976		Registration of Hazardous Substances and Manufacturer of Hazardous Substances
AO 220 s. 1974	13 Jun 1974		Drugs: Current Good Manufacturing Practice in Manufacture, Processing, Packaging or Holding
AO 151 s. 1971	18 Aug 1971		Regulation Part C-7 Drug and Devices: Certification of Antibiotics
AO 149 s. 1971	19 Jul 1971		Unauthorized Purchase, Possession, Display or Sale of Government-Owned Drugs, Medicines or any Other Medicinal Items
AO 131 s. 1970	15 Oct 1970		Regulation Part C-3.2: Drugs Prohibition of Use of More Than One Name for a Given Formulation
AO 126 s. 1970	06 Aug 1970		Regulation Part C-10: Drugs; Statement of Lot Number, Expiration Date, Registration Number and Storage Conditions of Pharmaceutical Specialties
AO 109 s. 1969	15 August 1969		Regulation Part C-1: Drugs Labeling: Prescription Drugs Label Symbol
AO 101 s. 1969	25 April 1969		Regulation Part C-9: Drugs: Registration of Drugs and Pharmaceutical Specialties
AO 92 s. 1968	03 December 1968		Rules and Regulations Covering the Sale, Distribution, Dispensing, Importation, Manufacture of Depressant and Stimulant Drugs
AO 89 s. 1968	03 October 1968		Exemption of Certain Drugs from Prescription Requirements
AO 61 s 1968	5 Mar 1968		General Regulations for the Enforcement of the Food, Drug & Cosmetic Act (C-3 Misbranding-Drugs & Devices)

BUREAU CIRCULARS

BFAD ISSUANCE	Date Issued	Date Posted	SUBJECT
BC 2007-011	01 Oct 2007	19 Oct 2007	Adoption of the Association of Southeast Asian Nations Common Technical Documents (ACTD) and Common Technical Requirements (ACTR) on the Pharmaceutical Product Registration for Human Use
BC 2006-008A	08 Oct 2007	16 Oct 2007	Amendment to Bureau Circular No. 008 s. 2006, the Subject of which is the "Lifting of Moratorium on the Conduct of Bioavailability / Bioequivalence Studies for Selected Pharmaceutical Products and Bureau Circular No. 2007-005 or the "Supplemental Guidelines for the Processing of Principal Certificate of Product Registration", and Providing for the Procedures and/or Guidelines thereof.
BC 2006-011	26 June 2006		Specific Operational Instructions Implementing Administrative Order No. 2005-0031 dated December 7, 2005, Subject: Guidelines and Procedure for the Issuance of the Principal Certificate of Product Registration and the Listing of Identical Drug Products based on the Identity of Manufacturer and Pharmaceutical Formulation
BC 2006-009	22 May 2006		Amendment to Bureau Circular No. 06 s. 2005 - List of Recognized Laboratories
BC 2006-008	27 Apr 2006		Lifting of Moratorium on the Conduct of Bioavailability/ Bioequivalence Studies for Selected Pharmaceutical Products
BC 2006-007	21 Mar 2006		Amendment to Bureau Circular No. 2006-005 re: Guidelines for the Submission of Application for Automatic Renewal Registration of Pharmaceutical Products, Medical Devices, Prepackaged Food and Food Products, and Household Hazardous Substances
BC 2006-005	22 Feb 2006		Guidelines for the Submission of Application for Automatic Renewal Registration of Pharmaceutical Products, Medical Devices, Prepackaged Food and Food Products, and Household Hazardous Substances
BC 18 s. 2005	12 Oct 2005		New Advisory on Labeling Selective Cycloxygenase-2 (COX-2) Inhibitors and Non-steroidal Anti-inflammatory Drugs (NSAIDS)
BC 15 s 2005	14 July 2005		Parecoxib (Dynastat)
BC 14 s 2005	6 July 2005		Gene Therapy
BC 12 s 2005	20 June 2005		BFAD Quality Seal
BC 11 s 2005	7 June 2005		Revised Labeling of Selective COX-2 Inhibitor Drugs and NSAIDS
BC 8 s 2005	4 April 2005		Selective COX-2 Inhibitors
BC 7 s. 2005	02 Mar 2005		Full Implementation of the Lot or Batch Release Certification Requirement
BC 6 s 2005	10 Feb 2005		List of Recognized Laboratories
BC 5 s 2005	03 Jan 2005		Black box warning for all antidepressant drugs
BC 4 s. 2005	01 Feb 2005		Revised Fees for Seminar on Licensing of Drug Establishments
BC 3 s 2005	19 Jan 2004		Submission of Site Information File
BC 2 s. 2005	10 Jan 2005		Revised Fees for Seminar on Licensing of Drug Establishments
BC 1 s 2005	4 Jan 2005		Classification of all Injectable Hyaluronic Acid as Device
BC 20 s. 2004	13 Dec 2004		Submission of Application for Registration in Accordance with the Asean Common Technical Document (ACTD) Format
BC 19 s 2004	26 Nov 2004		Delisting of ROFECOXIB from Bureau of Food and Drugs REGISTRY OF DRUG PRODUCTS
BC 14 s 2004	12 Oct 2004		Submission of adverse drug reaction reports of COX-2 inhibitors as part of safety monitoring
BC 07 s. 2004	3 Jun 2004		Registration of Veterinary Products
BC No. 4-a s. 2004	31 Mar 2004		Different Brand Names for Narcotic/Opioid Analgesic Drugs for Cancer Pain
BC No. 04 s. 2004	30 Mar2004		Reiterating Memorandum Circular No. 008 s. 1988) (RE: DRUG AND MEDICAL DEVICE REGISTRATION)
BC No. 03 s. 2004	26 Mar 2004		Guidelines for the Registration and Performance Validation of Methamphetamine (MET)/Tetrahydrocannobinol (THC) Drug Screening Test Kits
BC No. 02 s. 2004	10 Feb 2004		Classification of GINKGO BILOBA as drugs
BC No. 05-b s. 2003	10 Apr 2003		Attendance in Licensing seminars as a requirement in the application for a license to operate of a drug establishment / drug outlet (A.O. 56 S 1989)
BC No. 05-a s. 2003	10 April 2003		Lifting of Moratorium on the Acceptance of Application for Initial Registration of Pharmaceutical Products
BC No. 05 s. 2003	10 April 2003		Classification of Hemodialysis Products as Drugs
BC No. 02 s. 2003	13 Feb 2003		Classification of Paracetamol syrup / suspension 120 mg/5mL and 125 mg/5mL
BC No. 03 s. 2003	17 Mar 2003		Mandatory printing of boxed warning on all Phenylpropanloamine (PPA) containing products (OTC and RX)
BC No. 03-a s. 2003	17 Mar 2003		Mandatory dissemination of information regarding the precaution/warning of drug products containing PHENYLPROPANOLAMINE (PPA)
BC No. 05-a s. 2003	10 Apr 2003		Lifting of Moratorium on the Acceptance of Application for Initial Registration of Pharmaceutical Products
BC 3-a s 2003	17 Mar 2003		Mandatory Dissemination of Information Regarding the Precaution/Warning of Drug Products containing Phenylpropanolamine (PPA)
BC 12 s. 2002	25 Oct 2002		Reiterating the Ban on the Use of Chloramphenicol in Food Producing Animals
BC 5 s. 2002	04 Apr 2002		Extension of the Validity Period of Initial and Renewal Registration of In-Vitro Diagnostic Reagents/Kits
BC 3 s. 2002	31 Jan 2002		Reclassification of Sambong 250mg Tablet from Over-The-Counter (OTC) to Household Remedy
BC 1 s. 2002	18 Jan 2002		Notarized Application Forms for Product Registration
BC 17 s. 2001	29 Nov 2001		Classification of Certain Drug Products
BC 16 s. 2001	20 Nov 2001		Guidelines for the Immediate Processing of Applications for Initial Registration of Pharmaceutical Products
BC 15-A s. 2001	13 Nov 2001		Amendment to BFAD Circular No. 23 Dated 16 September 1994
BC 15 s. 2001	26 Oct 2001		Guidelines for the Immediate Processing of Pending Applications for Renewal Registration of Pharmaceutical Products
BC 14 s. 2001	26 Oct 2001		Amendment to Bureau Circular No. 13-A s. 2001 “Over-The-Counter (OTC) Drugs Reclassified as Household Remedies"
BC 13-A s. 2001	17 Oct 2001		Amendment To Bureau Circular No. 11 s. 2001 “Over-The Counter (OTC) Drugs Reclassified as Household Remedies
BC 12 s. 2001	05 Oct 2001		Addendum to Bureau Circular No. 6-A s. 2001Dated June 11, 2001
BC 11 s. 2001	20 Aug 2001		Over-the-Counter (OTC) Drug Reclassified as Household Remedies
BC 10 s. 2001	10 Aug 2001		Submission of Site Information File and updating
BM 10 s. 2001	25 Jun 2001		Reduction on the Required Number of Antibiotic Samples for Analysis for Batch Certification.
BC 6-A s. 2001	11 Jun 2001		Revised Minimum Required Samples for Laboratory Analysis
BC 4 s. 2001	20 Apr 2001		Extension of the Validity of Monitored Release Study
BC 3 s 2001	05 Apr 2001		Cancellation of the Certificates of Product Registration, Seizure and Confiscation of BFAD registered products, which do not conform to their registered specification.
BO 28-A s. 2001	15 Feb 2001		Requirements and Fees for Review of Pharmaceutical Products by the Advisory Committee to BFAD (ACB)
BC 5-B s. 2000	03 Aug 2000		Standard Policy on Labeled Potency of Pharmaceutical Products
BC 4 s. 2000	14 Jun 2000		Implementation of Administrative Order No. 13 s. 1999 “Use of Hydroquinone and/or Tretinoin (Retinoic Acid)
BC 3-A s. 2000	08 Jun 2000		Amendment to FDA Circular No. 2. s. of 1982 on the Importation of Semi-Synthetic Antibiotics
BC 3 s. 2000	28 Feb 2000		Submission of Test Procedures and Test Specifications for Products to be Included in the Philippine Pharmacopoeia
BC 1 s. 2000	13 Jan 2000		Moratorium on the Acceptance of Application for Initial Registration of Pharmaceutical Products
BC 19 s. 1999			Re-Iterating Section 20 (b)(1)(B) of R.A. 3720 as Amended Section 12 of E.O. 175 and Section 29-A of E.O. 175
BC 17 s. 1999	23 Jul 1999		Transfer of Processing of Brand Name Clearance for Pharmaceutical Products to the Intellectual Property Office (IPO)
BC 17-A s. 1999	23 Jul 1999		Resumption of Acceptance of Application for Registration of Branded Ethical/Prescription Pharmaceutical Products
BC 16 s. 1999	06 Jul 1999		Amending BFAD MC # 22 Date September 8, 1994 Regarding Inventory, Proper Disposal and/or Destruction of Used Vials or Bottles
BC 13-A s. 1999	14 Jun 1999		Moratorium on the Conduct of Bioavailability/ Bioequivalence Studies for Pharmaceutical Products Included in the List B’ (Products with Reported Problems on Bioavailability/ Bioequivalence)
BC 12-B s. 1999	11 Jun 1999		Phasing-Out the Registration of Branded Version of Registered Unbranded Drug Product and Unbranded Version of Registered Branded Drug Product (Memorandum Circular No.10-A s. 1992)
BC 11 s. 1999	01 Jun 1999		Certification of Registrations' Annotation of Suspension/Cancellation of Drug or Drug Product Combination Found to be Adulterated/Misbranded
BC 7 s. 1999	18 Feb 1999		Re-iterating Article IV, Section 30 of Republic Act 5921
BC 5 s. 1998	03 Aug 1998		Extension of the Validity Period of Renewal Registration of Medical and Dental Devices
BC 8 s. 1997	30 Apr 1997		Implementation Details of BFAD Circular No.1. s. 1997
BC 5 s. 1997	19 Mar 1997		Revised Checklist of Requirements and the 1997 Guidelines for the Registration of Pharmaceutical Products
BC 1 s. 1997	21 Jan 1997		Enforcement of the Requirement for Bioavailability Studies for Registration of Products Included in the List B’ (Prime) Under DOH-Administrative Order 67 s. 1989
BC 5 s. 1996	07 Aug 1996		Iterating Article IV, Section 25 of Republic Act 5921, as Amended.
BC 4 s. 1996	30 Jul 1996		Pertinent Provision of Republic Act (R.A.) 7581 Otherwise Known as the Price Act.
BO 67-B s. 1996	05 Jun 1996		Requiring the Inclusion of Warning Statement for Products Containing Sodium Metabisulfite and other Derivatives of this Sodium Salt
BC 3 s. 1996	22 Apr 1996		Selling of Drugs or Medicines to the Public
BC 4 s. 1995	17 Oct 1995		Period within which an Initial Conditional Registration shall be Processed and Issued
OO 22 s. 1991	18 Oct 1991		Guidelines for the Classification of Vitamins and Minerals as Drug or as Food
BC 12 s 1991	28 Jun 1991		Clarification of New Registration when there is a change of manufacturer
BFAD REG 1 s 1988	4 Jan 1988		Amended General Regulations for the Licensing of Drug Establishments
BFAD REG 5 s. 198